IDH2 and chondrosarcoma: To examine relative differences in acylcarnitine metabolism between mutant IDH and non-mutant chondrosarcomas, we compared means of acylcarnitine species in mutant IDH tumors to non-mutant tumors and calculated concentration fold changes (Table 3).